- Home
- STRO vs PMVP Comparison
STRO vs PMVP Comparison
Compare STRO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- PMVP
- Stock Information
- Founded
- STRO 2003
- PMVP 2013
- Country
- STRO United States
- PMVP United States
- Employees
- STRO N/A
- PMVP N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- STRO Health Care
- PMVP Health Care
- Exchange
- STRO Nasdaq
- PMVP Nasdaq
- Market Cap
- STRO 77.7M
- PMVP 71.9M
- IPO Year
- STRO 2018
- PMVP 2020
- Fundamental
- Price
- STRO $0.90
- PMVP $0.88
- Analyst Decision
- STRO Hold
- PMVP Strong Buy
- Analyst Count
- STRO 7
- PMVP 1
- Target Price
- STRO $5.47
- PMVP $5.00
- AVG Volume (30 Days)
- STRO 1.2M
- PMVP 313.5K
- Earning Date
- STRO 05-08-2025
- PMVP 05-09-2025
- Dividend Yield
- STRO N/A
- PMVP N/A
- EPS Growth
- STRO N/A
- PMVP N/A
- EPS
- STRO N/A
- PMVP N/A
- Revenue
- STRO $66,434,000.00
- PMVP N/A
- Revenue This Year
- STRO N/A
- PMVP N/A
- Revenue Next Year
- STRO N/A
- PMVP N/A
- P/E Ratio
- STRO N/A
- PMVP N/A
- Revenue Growth
- STRO N/A
- PMVP N/A
- 52 Week Low
- STRO $0.52
- PMVP $0.81
- 52 Week High
- STRO $5.17
- PMVP $1.85
- Technical
- Relative Strength Index (RSI)
- STRO 50.82
- PMVP 39.59
- Support Level
- STRO $0.86
- PMVP $0.87
- Resistance Level
- STRO $0.99
- PMVP $0.94
- Average True Range (ATR)
- STRO 0.09
- PMVP 0.06
- MACD
- STRO 0.00
- PMVP 0.01
- Stochastic Oscillator
- STRO 68.44
- PMVP 50.38
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.